Skip to main content

Table 1 Study population characteristics

From: Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes

  All Receiving statin therapy
n = 924 n = 730
Clinical
Age (years) 65 [58, 70] 65 [59, 70]
Male sex, n (%) 597 (65) 486 (67)
Diabetes duration (years) 11 [6, 17] 11 [6, 17]
Body mass index (kg/m2) 29 [26, 33] 30 [27, 33]
Systolic blood pressure (mmHg) 136 (17) 135 (16)
Diastolic blood pressure (mmHg) 80 (11) 80 (10)
Known coronary heart disease n (%) 162 (18) 140 (19)
Lipids
Total cholesterol (mmol/l) 4.1 [3.5, 4.8] 3.9 [3.4, 4.5]
Low density cholesterol (mmol/l) 2.0 [1.6, 2.6] 1.8 [1.5, 2.3]
High density cholesterol (mmol/l) 1.2 [1.0, 1.4] 1.2 [1.0, 1.4]
Cholesterol remnants (mmol/l) 0.8 [0.5, 1.1] 0.7 [0.5, 1.0]
Triglyceride (mmol/l) 1.7 [1.2, 2.4] 1.7 [1.2, 2.4]
Other laboratory values
Albuminuria (%) 212 (23.3) 165 (22)
 Microalbuminuria (%) 149 (16) 116 (16)
 Macroalbuminuria (%) 63 (7) 49 (7)
Creatinine (μmol/l) 78 [65, 96] 78 [66, 96]
Haemoglobin A1c (%) 55 [48, 66] 54 [48, 65]
Haemoglobin A1c (mmol/mol) 7.2 [6.5, 8.2] 7.1 [6.5, 8.1]
Medication
Statins, n (%) 730 (79)
Metformin, n (%) 670 (73) 552 (76)
DPP4 inhibitors, n (%) 88 (10) 71 (10)
Sulfonylurea, n (%) 142 (15) 107 (15)
Glucagon-like peptide-1 receptor agonists, n (%) 226 (25) 189 (26)
Insulin, n (%) 428 (46) 334 (46)
Beta blockers, n (%) 221 (24) 186 (26)
Angiotensin-converting enzyme inhibitors, n (%) 354 (38) 297 (41)
Angiotensin II receptor blockers, n (%) 359 (40) 298 (41)
Calcium antagonists, n (%) 294 (32) 250 (34)
Diuretics, n (%) 452 (49) 376 (52)
Antiplatelets, n (%) 607 (66) 508 (70)
  1. Continuous traits are reported as mean (standard deviation) or median [interquartile range] in case of non-normal distribution